The presentation will be focusing on the Firefly Dx detection system and their microfluidic bio-agent autonomous networked detector (M-BAND) technology. The Firefly Dx is a handheld detection system based on polymerase chain reactions (PCR), and in tests it has been successful in detecting and identifying samples within a 20-minute timeframe. The system utilizes cartridges that contain the necessary reagents and other materials needed to complete diagnostic testing.
The company states that similar testing procedures in a laboratory can take several hours or days. The Firefly Dx system was developed to meet the needs of the medical and emergency response communities' needs, specifically in areas where laboratory tests would be impractical or impossible.
The M-BAND system analyzes air samples in order to detect the presence of biological material including toxins, pathogens and other airborne contaminants. It also utilizes wireless networks to notify personnel of any threats or changes in an area.
Caragol's presentation will take place at 1 p.m. PT at the Encore at Wynn in Las Vegas, Nevada.
PositiveID specializes in the development and manufacture of diagnostic tools for defense purposes.